A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...

Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a ...

The team from Hospital Universitario Ramon y Cajal in Spain conducted an observational study on 725 MS patients, across 13 ...

Data underscore the potential to leverage comprehensive epigenomic profiling from a simple blood test to explore central nervous system disease ...

Rutgers Health researchers will enroll primary or secondary progressive multiple sclerosis (p-MS) patients to see if an ...

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of ...

The online program "Eating Well with MS" improved dietary behavior among multiple sclerosis patients and was deemed valuable, ...

In this study, Monreal and co-authors analyzed blood samples that were collected within 12 months of disease onset from 725 MS patients across 13 hospitals in Spain and Italy. Most participants (70.2% ...

Novartis' new data for Kesimpta showed reduced disability progression in relapsing multiple sclerosis patients. Continuous ...

New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that ...

U.S. District Court Judge Julia E. Kobick sentenced Jaclyn McQueen, 44, of Dedham on Wednesday to three years of probation on ...

New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients: Basel Friday, September 20, 2024, 12:00 Hrs [IST] Novartis announced new data ...